Nitra monetizes via card interchange
Nitra
The key point is that Nitra can price like a low cost workflow tool because the real money comes after the customer starts spending. A clinic may feel like it is adopting software for bill pay, approvals, and bookkeeping sync, but Nitra gets paid when that clinic runs supplies, vendor bills, and day to day operating spend through the card. That makes usage depth, not seat count, the real driver of revenue and margin.
-
The software is there to change behavior. Unlimited cards, role based controls, automatic coding, receipt matching, and bill pay workflows make the Nitra card the default way a practice buys and pays, which lifts purchase volume and keeps that volume from leaking to another card.
-
The economics look more like Ramp or Brex than a normal vertical SaaS company. Those businesses also use software to win distribution, then earn most revenue from interchange on payment volume. In Nitra’s case, the company estimates roughly a 1 percent net take on volume after bank, network, and rewards costs.
-
That model changes what expansion means. A bigger customer is not mainly one with more users, it is one that routes more medical supply purchases, invoices, and recurring operating expenses through Nitra. The planned procurement marketplace matters because it can add vendor rebates and better pricing on top of interchange.
The next phase is turning the card from the monetization engine into just one rail inside a broader purchasing system. If Nitra becomes the place where clinics decide what to order, which vendor to use, and how to pay, revenue will keep scaling with spend while margins broaden through procurement rebates, premium automation, and eventually credit products.